$1,000 – $3,000 Paid Clinical Trials

440 studies

Standard inpatient Phase 1 studies with multi-day residential stays typically compensate $1,000–$3,000.

Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.

Showing 61–80 of 440 studies

$1,000 – $3,000 Paid Clinical Trials

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers

First-in-Human Single and Multiple Dose of KLA578-1 for Injection

Single-dose,First-in-human of KLA478

A Phase I Study of KLA318-2 Nanocrystal Injection

Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)

PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects

A Clinical Trial of MK-4646 With Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir in Healthy Adult Participants (MK-4646)

A Study to Assess the Absolute Bioavailability of Empasiprubart SC Administered With an Autoinjector and the Pharmacokinetic Noninferiority of Empasiprubart SC Versus Intravenous (IV) in Healthy Adult Participants

Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions

A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases

A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men and Women

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fasting Conditions

Relative Bioavailability and Impact of Rabeprazole for PF-07799933, Food-Effect for PF-07799933 and PF-07799544

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

Study of TGM-312-SC01 in Healthy Participants and Adults With MASH

Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants

Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting Conditions

A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function

A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects